Kaposi Sarcoma Associated With Systemic Corticosteroid Therapy
| Autor: | C. de la Torre, Manuel Cruces, B. González-Sixto, Alberto Conde, R. Pardavila, Eugenia Mayo |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Histology business.industry medicine.medical_treatment virus diseases Immunosuppression Dermatology medicine.disease Pathology and Forensic Medicine Herpes virus Corticosteroid therapy Infectious disease (medical specialty) Prednisone Epidemiology Immunology medicine Arteritis Sarcoma business medicine.drug |
| Zdroj: | Actas Dermo-Sifiliográficas (English Edition). 98:553-555 |
| ISSN: | 1578-2190 |
| DOI: | 10.1016/s1578-2190(07)70512-7 |
| Popis: | Kaposi sarcoma (KS) was first described in 1872 by Moritz Kaposi. Its epidemiology is suggestive of an infectious disease and in 1994 Chang and coworkers identified DNA sequences corresponding to a previously unidentified herpes virus—human herpes virus 8 (HHV-8)—in AIDS-associated KS biopsies. It is now believed that the presence of HHV-8 is a necessary condition but not sufficient on its own to cause KS. Other factors such as immunosuppression should also be considered and it is known that immunosuppressive therapy increases the risk of KS. We describe a patient who developed KS after prolonged prednisone therapy for temporal arteritis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect